Diana Sun

Lineage and species-specific long noncoding RNAs during erythro-megakaryocytic development

Vikram R. Paralkar, Tejaswini Mishra, Jing Luan et al. · Blood · 2014 · 182 citations · Full text

Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort

Jennifer A. Namazy, Lucie Blais, Elizabeth Andrews et al. · Journal of Allergy and Clinical Immunology · 2019 · 157 citations · Full text

Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancer

Matti Aapro, Paul Cornes, Diana Sun et al. · Therapeutic Advances in Medical Oncology · 2012 · 58 citations · Full text

Potential Cost Savings From Chemotherapy-Induced Febrile Neutropenia With Biosimilar Filgrastim and Expanded Access to Targeted Antineoplastic Treatment Across the European Union G5 Countries: A Simulation Study

Diana Sun, Tri Murti Andayani, Ahmed E. Altyar et al. · Clinical Therapeutics · 2015 · 55 citations

Expanded Access, Medicine, Cancer Management +9

Cost Savings from Anemia Management with Biosimilar Epoetin Alfa and Increased Access to Targeted Antineoplastic Treatment: A Simulation for the EU G5 Countries

Ivo Abraham, Lucy M. Han, Diana Sun et al. · Future Oncology · 2014 · 54 citations